Van der Harst D - Search Results

1

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.

Weijl NI, Van der Harst D, Brand A, Kooy Y, Van Luxemburg S, Schroder J, Lentjes E, Van Rood JJ, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: van der harst d. J Clin Oncol. 1993 Jul;11(7):1376-83. doi: 10.1200/JCO.1993.11.7.1376. J Clin Oncol. 1993. PMID: 8315436 Clinical Trial.

2

Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients.

Schaafsma MR, Fibbe WE, van der Harst D, Duinkerken N, Brand A, Osanto S, Franks CR, Willemze R, Falkenburg JH. Schaafsma MR, et al. Among authors: van der harst d. Br J Haematol. 1990 Oct;76(2):180-5. doi: 10.1111/j.1365-2141.1990.tb07869.x. Br J Haematol. 1990. PMID: 2094321 Clinical Trial.

3

Comparison between clonogenic and cytotoxic assays for measuring LAK cell activity.

Kluin-Nelemans HC, van der Harst D, van den Burgh JF, van Luxemburg S, Brand A. Kluin-Nelemans HC, et al. Among authors: van der harst d. Int J Cell Cloning. 1989 Jul;7(4):232-41. doi: 10.1002/stem.5530070405. Int J Cell Cloning. 1989. PMID: 2768841 Free article.

4

Lymphokine-activated killer cell functions in patients with leukemic B-lymphoproliferative diseases.

van der Harst D, Brand A, van Luxemburg-Heys SA, Kooy-Winkelaar EM, van Rood JJ. van der Harst D, et al. Blood. 1989 Nov 15;74(7):2464-70. Blood. 1989. PMID: 2804374 Free article.

5

Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.

Jansen JH, van der Harst D, Wientjens GJ, Kooy-Winkelaar YM, Brand A, Willemze R, Kluin-Nelemans HC. Jansen JH, et al. Among authors: van der harst d. Blood. 1992 Jul 15;80(2):478-83. Blood. 1992. PMID: 1352710 Free article.

6

Selective outgrowth of CD45RO+ V gamma 9+/V delta 2+ T-cell receptor gamma/delta T cells early after bone marrow transplantation.

van der Harst D, Brand A, van Luxemburg-Heijs SA, Kooij-Winkelaar YM, Zwaan FE, Koning F. van der Harst D, et al. Blood. 1991 Oct 1;78(7):1875-81. Blood. 1991. PMID: 1832995 Free article.

7

Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura.

van der Harst D, de Jong D, Limpens J, Kluin PM, Rozier Y, van Ommen GJ, Brand A. van der Harst D, et al. Blood. 1990 Dec 1;76(11):2321-6. Blood. 1990. PMID: 1701666 Free article.

8

Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones.

van der Harst D, Goulmy E, Falkenburg JH, Kooij-Winkelaar YM, van Luxemburg-Heijs SA, Goselink HM, Brand A. van der Harst D, et al. Blood. 1994 Feb 15;83(4):1060-6. Blood. 1994. PMID: 8111046 Free article.

9

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Falkenburg JH, Goselink HM, van der Harst D, van Luxemburg-Heijs SA, Kooy-Winkelaar YM, Faber LM, de Kroon J, Brand A, Fibbe WE, Willemze R, et al. Falkenburg JH, et al. Among authors: van der harst d. J Exp Med. 1991 Jul 1;174(1):27-33. doi: 10.1084/jem.174.1.27. J Exp Med. 1991. PMID: 2056279 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters